Amgen Profit Rises as Drug Sales, Prices Increase (Update3)
Amgen Inc., the world’s largest biotechnology company, said first-quarter profit climbed 15 percent as it boosted sales and prices on its drugs. Revenue for 2010 will be at the low end of previous forecasts due to costs of the U.S. health-care overhaul, the company said.

Read more on BusinessWeek